What the new Glooko EndoTool IV Cloud shows about our approach to healthcare technology – and why customer partnership matters as health systems prepare for the next generation of inpatient glycemic management.
Conversations about cloud migration tend to focus on reduced costs, predictable spending, reliability, and scalability. Those are all important, but an essential question in healthcare should be: What does that modernization make possible? How does it help care teams, patients, and the health systems supporting them?
At Glooko, our mission is to transform diabetes care by simplifying it and strengthening connections. Technology only advances that mission when it solves real problems, helping clinicians be more effective, reducing complexity for health system teams, and making trusted clinical capabilities easier to extend across an organization.
That is particularly important with inpatient glycemic management.
Hospitalized patients can experience rapidly changing glucose management needs and clinicians must manage the risks of both hypoglycemia and hyperglycemia within already demanding workflows. At the same time, these outcomes need to be more visible at a system level to enable reporting as part of CMS Hospital Harm electronic clinical quality measures.
Meeting that moment requires bringing together clinical intelligence, actionable analytics, intuitive workflows, and technology infrastructure providing workflows that support the way health systems actually operate.
Modernize the experience, keep the algorithm
That philosophy is central to Glooko EndoTool IV Cloud, the next generation, cloud-based iteration of our EndoTool IV inpatient insulin dosing solution.
EndoTool has an established clinical foundation: a patient-specific algorithm designed to provide insulin dosing recommendations based on each patient’s glucose response and relevant clinical factors. Glooko EndoTool IV Cloud brings that clinical intelligence into a modern SaaS experience designed around both clinical and technical teams.
For clinicians, that means a cleaner interface, fewer screens and clicks, and a streamlined path to the dosing recommendation and key patient information they need.
For IT teams, cloud delivery removes the need for on-prem servers and all the provisioning, networking, and security management that goes with it, freeing them up for more value creating work.
A technically modern product that adds friction at the bedside has missed the point. A clinically valuable solution that is hard to deploy, maintain, or scale ultimately limits how broadly that value can reach.
In short, cloud matters when it balances both needs.
Scaling clinical value is the real opportunity
For health systems, modernization is rarely about one application or one server. Leaders are being asked to improve quality and safety while managing workforce constraints, increasingly complex technology environments, and growing demands on IT. The opportunity is to make established clinical capabilities easier to operationalize across that environment.
For a health system evaluating EndoTool for the first time, Glooko EndoTool IV Cloud brings patient-specific insulin dosing together with a modern clinical experience and a deployment model built for today’s enterprise.
For hospitals that already use EndoTool, the opportunity is different but equally important: modernizing how the technology is delivered while retaining the underlying EndoTool clinical algorithm and core clinical decision-support approach their teams already know.
Sometimes the most meaningful innovation is making a trusted capability easier to use, support, or scale. “Innovation that matters” is how we frame this at Glooko.
Technology should enable the mission
As healthcare technology continues to evolve, we should resist defining progress simply by technical changes. The standard should be higher.
Does the technology make clinical workflows simpler? Does it help organizations deploy and manage trusted tools more effectively? Can it support more consistent approaches across increasingly complex health systems? And ultimately, does it help care teams focus more of their attention on the people they are caring for?
That is how we think about a cloud-first approach at Glooko.
Our goal is not to move diabetes and glycemic management to the cloud for its own sake. It is to help customers scale trusted clinical solutions, simplify how those solutions are deployed and supported, and strengthen connections across the care journey.
We’re in a moment in which glycemic safety, clinical usability, customer partnership, and responsible scale all matter more than ever.
Glooko EndoTool IV Cloud is one important way we’re helping health systems meet that moment.